Antiparasitic activities of novel pyrimidine N‐acylhydrazone hybrids.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 230, doi. 10.1002/ddr.21745
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2021 AND VI 82 AND IP 2
Results: 15
1
2
Synthesis and antimicrobial activity of the hybrid molecules between amoxicillin and derivatives of benzoic acid.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 198, doi. 10.1002/ddr.21739
- By:
- Publication type:
- Article
3
Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 149, doi. 10.1002/ddr.21746
- By:
- Publication type:
- Article
4
Issue Information.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 143, doi. 10.1002/ddr.21691
- Publication type:
- Article
5
Evaluation of the oral administration of α‐l‐guluronic acid on COX‐1 and COX‐2 gene expression profile in ankylosing spondylitis patients.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 296, doi. 10.1002/ddr.21756
- By:
- Publication type:
- Article
6
Synthesis and in vitro antileishmanial efficacy of benzyl analogues of nifuroxazide.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 287, doi. 10.1002/ddr.21755
- By:
- Publication type:
- Article
7
Drug encapsulating polysaccharide‐loaded metal nanoparticles: A perspective drug delivery system.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 145, doi. 10.1002/ddr.21754
- By:
- Publication type:
- Article
8
"Azole" as privileged heterocycle for targeting the inducible cyclooxygenase enzyme.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 167, doi. 10.1002/ddr.21753
- By:
- Publication type:
- Article
9
Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 278, doi. 10.1002/ddr.21751
- By:
- Publication type:
- Article
10
Sigma‐1 receptor antagonist (BD‐1063) potentiates the antinociceptive effect of quercetin in neuropathic pain induced by chronic constriction injury.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 267, doi. 10.1002/ddr.21750
- By:
- Publication type:
- Article
11
Allylphenols as a new class of human 15‐lipoxygenase‐1 inhibitors.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 259, doi. 10.1002/ddr.21749
- By:
- Publication type:
- Article
12
Effects of sinomenine on the proliferation, cytokine production, and regulatory T‐cell frequency in peripheral blood mononuclear cells of rheumatoid arthritis patients.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 251, doi. 10.1002/ddr.21748
- By:
- Publication type:
- Article
13
Evaluation of hyaluronic acid nanoparticle embedded chitosan–gelatin hydrogels for antibiotic release.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 241, doi. 10.1002/ddr.21747
- By:
- Publication type:
- Article
14
Superiority of cilostazol among antiplatelet FDA‐approved drugs against COVID 19 M<sup>pro</sup> and spike protein: Drug repurposing approach.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 217, doi. 10.1002/ddr.21743
- By:
- Publication type:
- Article
15
New multitarget directed benzimidazole‐2‐thiol‐based heterocycles as prospective anti‐radical and anti‐Alzheimer's agents.
- Published in:
- Drug Development Research, 2021, v. 82, n. 2, p. 207, doi. 10.1002/ddr.21740
- By:
- Publication type:
- Article